263
Participants
Start Date
November 26, 2003
Primary Completion Date
March 29, 2012
Study Completion Date
February 8, 2023
bleomycin sulfate
At least one course administered
cisplatin
At least one course administered
etoposide
At least one course administered
ifosfamide
Given in a dose-dense sequential fashion
oxaliplatin
Given in a dose-dense sequential fashion
paclitaxel
Given in a dose-dense sequential fashion
Centre Hospitalier de Rodez, Rodez
Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille
Centre Regional Francois Baclesse, Caen
C.H.U. de Brest, Brest
Institut Claudius Regaud, Toulouse
Institut Bergonie, Bordeaux
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier
Centre Eugene Marquis, Rennes
Centre Hospitalier Universitaire Bretonneau de Tours, Tours
CHU de Grenoble - Hopital de la Tronche, Grenoble
CRLCC Nantes - Atlantique, Saint-Herblain
Centre Paul Papin, Angers
Institut Jean Godinot, Reims
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
Hopital Notre-Dame de Bon Secours, Metz
Centre Oscar Lambret, Lille
Centre Leon Berard, Lyon
Hopital Europeen Georges Pompidou, Paris
Hopital Tenon, Paris
Centre Henri Becquerel, Rouen
M. D. Anderson Cancer Center at University of Texas, Houston
Centre Antoine Lacassagne, Nice
Institut Gustave Roussy, Villejuif
National Cancer Institute - Bratislava, Bratislava
UNICANCER
OTHER